[go: up one dir, main page]

AR023876A1 - Composiciones para el tratamiento de afecciones esofagicas. - Google Patents

Composiciones para el tratamiento de afecciones esofagicas.

Info

Publication number
AR023876A1
AR023876A1 ARP000102198A ARP000102198A AR023876A1 AR 023876 A1 AR023876 A1 AR 023876A1 AR P000102198 A ARP000102198 A AR P000102198A AR P000102198 A ARP000102198 A AR P000102198A AR 023876 A1 AR023876 A1 AR 023876A1
Authority
AR
Argentina
Prior art keywords
compositions
esofagic
affections
treatment
gum
Prior art date
Application number
ARP000102198A
Other languages
English (en)
Original Assignee
Reckitt Benckiser Uk Helthcare Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Uk Helthcare Uk Ltd filed Critical Reckitt Benckiser Uk Helthcare Uk Ltd
Publication of AR023876A1 publication Critical patent/AR023876A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se han producido composiciones farmaceuticas que tienen propiedades bioadhesivas mejoradas mediante la combinacion de un alginato, goma xántica y/o gomacarragenano y un glucomanano y/o un galactomanano. La composicion puede surtir sobre las superficies mucosas ambos efectos: protector y curativo.
ARP000102198A 1999-05-05 2000-05-05 Composiciones para el tratamiento de afecciones esofagicas. AR023876A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9910212.1A GB9910212D0 (en) 1999-05-05 1999-05-05 Improvements in or relating to organic compositions

Publications (1)

Publication Number Publication Date
AR023876A1 true AR023876A1 (es) 2002-09-04

Family

ID=10852720

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102198A AR023876A1 (es) 1999-05-05 2000-05-05 Composiciones para el tratamiento de afecciones esofagicas.

Country Status (15)

Country Link
US (1) US6610667B1 (es)
EP (2) EP1173218B1 (es)
JP (1) JP2002544176A (es)
CN (1) CN1173743C (es)
AR (1) AR023876A1 (es)
AT (2) ATE417602T1 (es)
AU (1) AU774966B2 (es)
BR (1) BR0010209A (es)
CA (1) CA2371031C (es)
DE (2) DE69940131D1 (es)
ES (1) ES2251997T3 (es)
GB (2) GB9910212D0 (es)
PL (1) PL199445B1 (es)
WO (1) WO2000067799A1 (es)
ZA (1) ZA200109073B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368013B (en) * 2001-02-19 2004-07-28 Richard Orlando Brown An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
ITRM20030154A1 (it) * 2003-04-03 2004-10-04 D M G Italia S R L Sciroppo antireflusso.
CA2523735C (en) * 2003-04-25 2012-09-18 Reckitt Benckiser Healthcare (Uk) Limited Thickenable compositions
WO2006085987A2 (en) 2004-07-09 2006-08-17 University Of Iowa Research Foundation Rna interference in respiratory epitheial cells
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee
JP4775807B2 (ja) * 2004-12-02 2011-09-21 株式会社 メドレックス 局所麻酔薬物含有ゼリー剤
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
ES2379723T3 (es) * 2005-10-05 2012-05-03 Fmc Biopolymer As Composiciones y métodos de gelificación
EP1859786A1 (en) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
BRPI0704542B8 (pt) * 2007-05-15 2021-05-25 Univ Estadual Campinas Unicamp composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento
AU2014262248B2 (en) * 2007-07-30 2017-05-04 Inovobiologic, Inc. Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
AU2008321395B2 (en) * 2007-11-13 2013-03-14 Viropharma Biologics Llc Corticosteroid compositions
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
CA2739668C (en) 2008-01-04 2016-10-11 Schabar Research Associates Llc The use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
CN104706616A (zh) * 2008-02-08 2015-06-17 高露洁-棕榄公司 泡腾组合物
EP2296670B1 (en) 2008-05-13 2013-02-27 Apharm S.r.l. Glycosaminoglycan oral use and compositions
CN102014876B (zh) * 2008-05-15 2013-03-27 弗门尼舍有限公司 活性成分递送系统
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
WO2010136872A2 (en) 2009-05-25 2010-12-02 Pharcoterm S.R.L. Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
US9636360B2 (en) * 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
IT201600088648A1 (it) * 2016-08-31 2018-03-03 Alpiflor S R L Composizione nutrizionale o farmaceutica ed integratore alimentare contenente detta compsizione nutrizionale o farmaceutica
IT201600121617A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione per il trattamento del reflusso gastroesofageo
IT201600121601A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
CN106420773A (zh) * 2016-12-21 2017-02-22 郑州莉迪亚医药科技有限公司 一种治疗放射性肠炎的中西药组合物及其制备方法和应用
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
CA3092619A1 (en) * 2018-03-02 2019-09-06 Pharagen Llc Formulations for treating acid reflux comprising sodium alginate
WO2019172261A1 (ja) * 2018-03-05 2019-09-12 国立大学法人東京大学 食道狭窄防止材料
CN109432232B (zh) * 2018-12-07 2021-11-26 纽湃腾（北京）医药科技有限公司 一种改善调节胃食管反流的海藻酸盐组合物及应用
CN109432233A (zh) * 2018-12-07 2019-03-08 纽湃腾（北京）医药科技有限公司 一种含有猴头菇提取物的抑反流护胃组合物及应用
CN110840853A (zh) * 2019-10-26 2020-02-28 张强 胃镜检查用咀嚼或含化型口咽部局麻药及服用方法
KR20230051164A (ko) 2020-07-15 2023-04-17 샤바르 리서치 어소시에이츠 엘엘씨 급성 통증의 치료 및 속쓰림의 중증도 및/또는 위험의 감소를 위한 이부프로펜 및 파모티딘으로 구성된 단위 경구 투여 조성물
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
US12514846B2 (en) 2020-07-15 2026-01-06 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
IT202000031421A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente saccarosio solfato o suoi derivati per il trattamento del reflusso gastrico
IT202000031409A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente gomma gellano e suo uso per il trattamento del reflusso gastrico
IT202000031433A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizioni comprendenti saccarosio octasolfato per il trattamento del reflusso gastrico
WO2022130358A1 (en) * 2020-12-18 2022-06-23 Drugs Minerals And Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L. Multicomponent composition comprising a gellan gum and use thereof for the treatment of gastric reflux

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57133170A (en) * 1981-02-12 1982-08-17 Kikusui Kagaku Kogyo Kk Thermochromic coating compound with colorful pattern
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
JP3802555B2 (ja) * 1991-12-17 2006-07-26 フイズ テクノロジーズ リミテッド 潰瘍予防及び治療組成物並びに方法
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same

Also Published As

Publication number Publication date
EP1614431A2 (en) 2006-01-11
EP1614431A3 (en) 2006-03-01
ES2251997T3 (es) 2006-05-16
CN1349418A (zh) 2002-05-15
ZA200109073B (en) 2003-01-29
GB0010669D0 (en) 2000-06-28
JP2002544176A (ja) 2002-12-24
DE60023873D1 (de) 2005-12-15
PL351134A1 (en) 2003-03-24
CA2371031C (en) 2008-09-30
ATE308997T1 (de) 2005-11-15
EP1173218B1 (en) 2005-11-09
DE60023873T2 (de) 2006-08-03
WO2000067799A1 (en) 2000-11-16
EP1614431B1 (en) 2008-12-17
BR0010209A (pt) 2002-02-19
AU774966B2 (en) 2004-07-15
GB2349570A (en) 2000-11-08
PL199445B1 (pl) 2008-09-30
GB2349570B (en) 2002-05-22
CA2371031A1 (en) 2000-11-16
AU4590000A (en) 2000-11-21
GB9910212D0 (en) 1999-06-30
DE69940131D1 (de) 2009-01-29
CN1173743C (zh) 2004-11-03
US6610667B1 (en) 2003-08-26
EP1173218A1 (en) 2002-01-23
ATE417602T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
AR023876A1 (es) Composiciones para el tratamiento de afecciones esofagicas.
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
NO20002741D0 (no) Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
PL360941A1 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
ES2181361T3 (es) Composiciones medicinales.
SI1898876T1 (sl) MUKOADHEZIVNE FARMACEVTSKE OBLIKE, KI VSEBUJEJO KSILOGlUKAN IN SO UPORABNE V MEDICINSKIH SREDSTVIH IN APLIKACIJSKIH OBLIKAH
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
HRP20090381T1 (en) Compositions comprising drospirenone molecularly dispersed
PL375621A1 (pl) Kompozycje farmaceutyczne zawierające flawonoidy i mentol
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
CY1108548T1 (el) Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
HRP20070431T3 (en) Use of nail restructuring compositions for topical application in onychoschizia
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
DE69917796D1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
MXPA04001398A (es) Metodo para el tratamiento y prevencion de dolor e inflamacion con glucosamina y un inhibidor selectivo de ciclooxigenasa-2 y composiciones para el mismo.
BR0314300A (pt) Aplicação de substâncias para a proteção da pele
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
BR0213934A (pt) Composições orais sólidas

Legal Events

Date Code Title Description
FB Suspension of granting procedure